Yatai Group (600881): Improved regional supply pattern is expected to bring performance elasticity
Yatai Group (600881): The pattern of cement supply and demand improves the steady development of the pharmaceutical sector
Yatai Group (600881) Company Renewal report: industrial structure shift enters a New stage
Yatai Group (600881) comments: profit restoration of northeast cement leader with diversified business is worth looking forward to.
Yatai Group (600881) announcement comments: 2016 performance turnround to profit inflection point
[Huatai] Yatai Group: regional leading industry upgrading, transformation layout is worth looking forward to
Yatai Group (600881) Annual report comment: the layout of upgrading and transformation of regional leading industries is worth looking forward to.
[Guotai Junan] Yatai Group: revitalizing the capital construction leader in the Northeast, determined to increase the pharmaceutical industry
Yatai Group (600881) comments: the revitalization of infrastructure in Northeast China will increase the pharmaceutical industry.
Comments on the quarterly report of Yatai Group (600881): when the adjustment and transformation of industrial structure is going on
【国泰君安】亚泰集团2015年三季报点评:产业结构调整,转型进行时
【国泰君安证券】亚泰集团:重识金融平台公司,产业换档亦渐入正轨
【国泰君安证券】亚泰集团:产业结构“换档”,开启新周期
【申银万国证券】亚泰集团:传统业务发展平稳,医药领域转型可期
【长江证券】亚泰集团:上调增发底价,凸显投资价值,继续推荐
【宏源证券】亚泰集团:投资收益为主,地产盈利回升
【长江证券】亚泰集团:区域振兴+业务转型,存在持续修复空间
亚泰集团(600881)三季报点评:主营业务持续低迷 投资收益贡献主要利润
【信达证券】亚泰集团:主营业务持续低迷,投资收益贡献主要利润
【信达证券】亚泰集团:主营业务低迷,业绩大幅下滑
No Data